Related Experiment Video
Updated: Jul 28, 2026
06:27
Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Structure of warfarin in solution
Journal of Medicinal Chemistry
|November 1, 1977
Summary
Warfarin exists in solution as three interconverting tautomers: two cyclic hemiketals and a minor open-chain form. Researchers determined the configurations and conformations of these warfarin structures using NMR spectroscopy.
Area of Science:
- Medicinal Chemistry
- Organic Chemistry
- Structural Chemistry
Background:
- Warfarin is a widely used anticoagulant.
- Understanding the solution-state structure of warfarin is crucial for its pharmaceutical development and efficacy.
- Previous studies have not fully elucidated the tautomeric equilibrium and stereochemistry of warfarin in solution.
Purpose of the Study:
- To identify and characterize the different tautomeric forms of warfarin in solution.
- To assign the absolute configurations and major conformations of the identified warfarin tautomers.
- To provide a detailed structural understanding of warfarin relevant to its pharmacological activity.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy was employed to analyze warfarin in solution.
- Analysis included detailed examination of chemical shift and coupling constant parameters.
- Comparison with structurally fixed model compounds aided in configuration assignments.
Main Results:
- Warfarin in solution exists as an equilibrium mixture of three tautomers.
- Two major tautomers identified as cyclic diastereomeric hemiketals.
- A third, minor tautomer identified as the open-chain intermediate form.
- Configurations and major conformations of all tautomers were assigned.
Conclusions:
- The study successfully characterized the solution-state tautomerism of warfarin.
- The assigned configurations and conformations provide critical structural insights.
- This detailed structural information can inform future drug design and optimization of warfarin-based therapies.
Related Concept Videos
04:01Factors Affecting Solubility
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:15Theories of Dissolution: Diffusion Layer Model
Dissolution, the process by which drug particles dissolve in a solvent, is explained by the diffusion layer model, a theoretical framework that simulates the absorption of oral drugs and allows us to analyze experimental data.
This process starts with a thin layer, saturated with the drug, forming at the interface between the solid and liquid. The solute then diffuses from this layer into the main solution. The Noyes-Whitney equation suggests that the rate of dissolution relies on the diffusion...
This process starts with a thin layer, saturated with the drug, forming at the interface between the solid and liquid. The solute then diffuses from this layer into the main solution. The Noyes-Whitney equation suggests that the rate of dissolution relies on the diffusion...
01:16Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...